TREATMENT OF BRONCHOPULMONARY ASPERGILLOS IS WITH ALLERGIC MANIFESTATIONS

The base of current management of bronchopulmonary aspergillosis' with allergic manifestations (BPAAM) is glucocorticosteroid treatment. The se hormones are introduced in a mean dose 0.5 mg/kg (by prednisolone) to correct bronchial obstruction. reduce eosinophilia and resolve (com pletely or partially), infiltrates in the lungs. This being achieved, the dose is lowered to warrant maintenance. Minimal doses or discontin uation of glucocorticosteroids may be used in case of adjuvant indomet hacin (0.025 three times a day) or plasmapheresis administration. In r emission, fungistatic means with glucocorticosteroids or without them (in the absence of bronchial obstruction) are proper inhalations in BP AAM are ineffective. Individual schemes of the disease treatment may v ary in wide range.